🔱 Intended Use: For research and laboratory purposes only. Not for human consumption, medical, or veterinary use.

🔬 What Retatrutide Is

Retatrutide is a triple-agonist peptide, meaning it activates three key metabolic hormone receptors:
•🧩 GLP-1 receptor – improves blood-sugar control and reduces appetite
•⚡ GIP receptor – enhances insulin release and supports metabolic regulation
•🔥 Glucagon receptor – increases energy expenditure and fat metabolism

Because it targets three pathways at once, it is considered more potent than single-pathway drugs such as semaglutide or even dual-agonists like tirzepatide.

⚖️ Weight-Loss Effects (Clinical Trials)

In phase 2 clinical studies:
•📉 Up to ~24% average weight loss after 48–72 weeks (dose-dependent)
•🏆 Some cohorts approached ~30% weight loss, nearing bariatric-surgery ranges

Additional improvements were seen in:
•🩸 Blood sugar
•🧪 Cholesterol
•🫁 Liver fat (NAFLD/NASH)
•💓 Blood pressure

These results contribute to Retatrutide being viewed as a “next-generation” obesity therapy in development.

🚧 Common Side Effects

Aligned with other incretin-based therapies:
•🤢 Nausea
•🤮 Vomiting
•💩 Diarrhea or constipation
•🍽️ Reduced appetite
•💉 Injection-site reactions
Most effects were dose-related and generally improved over time.

Upgrade your experience with our premium pen kit!
Each set comes complete with:
•💉 12 high-quality needles for smooth, reliable use
•🎉 12 alcohol swabs to ensure optimal cleanliness
•🔥 A sleek metal case for protection and portability
•🔵 Blue pen, offered in 20 mg / 40 mg / 60 mg options to suit your needs